A derivative of Gly-Pro-Glu
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Trofinetide (acetate)

Item No. 38579

Technical Information
Formal Name
glycyl-2-methyl-L-prolyl-L-glutamic acid, acetate
Synonyms
  • NNZ-2566
Molecular Formula
C13H21N3O6 • XC2H4O2
Formula Weight
Purity
≥95%
A solid
DMF: 5 mg/mlDMSO: 10 mg/mlEthanol: 1 mg/mlPBS (pH 7.2): 10 mg/ml
SMILES
O=C([C@@](N1C(CN)=O)(CCC1)C)N[C@H](C(O)=O)CCC(O)=O.CC(O)=O
InChi Code
InChI=1S/C13H21N3O6.C2H4O2/c1-13(5-2-6-16(13)9(17)7-14)12(22)15-8(11(20)21)3-4-10(18)19;1-2(3)4/h8H,2-7,14H2,1H3,(H,15,22)(H,18,19)(H,20,21);1H3,(H,3,4)/t8-,13-;/m0./s1
InChi Key
WMGAIYMYGMFYKS-GAYVKDPFSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Trofinetide is a derivative of the neuroprotective tripeptide Gly-Pro-Glu, an N-terminal sequence found in insulin-like growth factor-1 (IGF-1).1 It decreases cell death induced by the protein phosphatase inhibitor okadaic acid (Item No. 10011490) in primary rat embryonic striatal neurons when used at a concentration of 10 nM. Trofinetide reduces brain expression of mRNA encoding IL-1β, TNF-α, IL-6, and E-selectin in a rat model of neuroinflammation induced by a penetrating ballistic-like brain injury.2 It reduces cortical and striatal infarct area in a rat model of brain injury induced by middle cerebral artery occlusion (MCAO) when administered at doses of 30 and 60 mg/kg.1 Trofinetide (100 mg/kg per day) reduces the number of dendritic spines and reverses deficits in social recognition and contextual fear conditioning, as well as decreases testicular weight gain, in an fmr1-/- knockout mouse model of fragile X syndrome.3 Formulations containing trofinetide have been used in the treatment of Rett syndrome.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Bickerdike, M.J., Thomas, G.B., Batchelor, D.C., et alNNZ-2566: A Gly-Pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke. J. Neurol. Sci. 278(1-2), 85-90 (2009).

    2. Wei, H.H., Lu, X.-C.M., Shear, D.A., et alNNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats. J. Neuroinflammation 6, 19 (2009).

    3. Deacon, R.M.J., Glass, L., Snape, M., et alNNZ-2566, a novel analog of (1-3) IGF-1, as a potential therapeutic agent for fragile X syndrome. Neuromolecular Med. 17(1), 71-82 (2015).